Patterson Announces Dental Leadership Changes
Patterson Dental Supply, a subsidiary of Patterson Companies (Nasdaq: PDCO), announced leadership changes effective July 19, 2021, aimed at accelerating growth in the dental market. Eric Shirley is appointed Senior Vice President of Business Development, focusing on future growth opportunities. Tim Rogan has been promoted to President, overseeing the dental business in North America. Both will report to CEO Mark Walchirk, who expressed confidence in the growth potential of the dental market under this new leadership structure.
- Leadership changes aim to accelerate growth in the dental market.
- Eric Shirley's new role focuses on strategic growth opportunities.
- Tim Rogan has a strong track record and extensive experience within the company.
- Transition may create temporary disruptions in leadership continuity.
- Potential experience gaps with new management structure.
Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO) today announced leadership changes designed to help accelerate the company’s growth in the dental market, effective July 19, 2021.
Eric Shirley, currently President of Patterson Dental, has been named as Senior Vice President of Business Development, with responsibility for identifying and executing on future growth opportunities within the dental industry. Shirley will continue to report to Mark Walchirk, President and Chief Executive Officer of Patterson Companies. Shirley’s new role reflects Patterson’s enterprise-wide focus on making strategic investments to deliver profitable growth and shareholder value.
With this transition, Tim Rogan has been promoted to President of Patterson Dental Supply Inc., and will also report to Mark Walchirk, with responsibility for the entire dental business in North America. Rogan is a 28-year Patterson veteran who currently serves as Senior Vice President and General Manager of Patterson Dental, and has built an impressive record of results during his tenure.
“We are confident the dental market continues to present attractive growth opportunities for Patterson,” said Mark Walchirk, President and Chief Executive Officer. “Eric’s new role will focus on evaluating these opportunities and help drive that strategic initiative. I am also very pleased to promote Tim Rogan, whose strong leadership, proven track record of success and industry experience make him an excellence choice to lead the Dental business going forward.”
About Patterson Companies Inc.
Patterson Companies Inc. (Nasdaq: PDCO) connects dental and animal health customers in North America and the U.K. to the latest products, technologies, services and innovative business solutions that enable operational and professional success. Our comprehensive portfolio, distribution network and supply chain are equaled only by our dedicated, knowledgeable people who deliver unrivaled expertise and unmatched customer service and support.
Learn more: pattersoncompanies.com
This press release contains, and our officers and representatives may from time to time make, certain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding future financial performance, and the objectives and expectations of management. Forward-looking statements often include words such as “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “seeks” or words of similar meaning, or future or conditional verbs, such as “will,” “should,” “could” or “may.”
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements. Any number of factors could affect our actual results and cause such results to differ materially from those contemplated by any forward-looking statements, including, but not limited to, the following: the COVID-19 pandemic and measures taken in response thereto; our dependence on relationships with sales representatives and service technicians to retain customers and develop business; potential disruption of distribution capabilities, including service issues with third-party shippers; our dependence on suppliers to manufacture and supply substantially all of the products we sell; the risk of the products we sell becoming obsolete or containing undetected errors; adverse changes in supplier rebates; the risk that private label sales could adversely affect our relationships with suppliers; our dependence on positive perceptions of Patterson’s reputation; risks inherent in acquiring and disposing of assets or other businesses and the risks inherent in integrating acquired businesses; our ability to comply with restrictive covenants in our credit agreement; our dependence on leadership development and succession planning; the risk that our governing documents and Minnesota law may discourage takeovers and business combinations; the effects of the highly competitive and consolidating dental and animal health supply markets in which we compete; exposure to the risks of the animal production business, including changing consumer demand, the cyclical livestock market, and other factors outside our control; risks from the formation of GPOs, provider networks and buying groups that may shift purchasing decisions and place us at a competitive disadvantage; increases in over-the-counter sales and e-commerce options for companion animal products or sales of companion animal products from non-veterinarian sources; change and uncertainty in the health care industry, including the effects of health care reform; failure to comply with existing or future U.S. or foreign laws and regulations including those governing the distribution of pharmaceuticals and controlled substances; public concern over the abuse of opioid medication in the U.S.; failure to comply with health care fraud or other laws and regulations; litigation risks, including the diversion of management’s attention, the cost of defending against such actions, the possibility of damage awards or settlements, fines or penalties, or equitable remedies (including but not limited to the revocation of or non-renewal of licenses) and inherent uncertainty; failure to comply with evolving data privacy laws and regulations; tax legislation; the risks inherent in international operations, including currency fluctuations; risks associated with information systems and cyber-security attacks; disruptions from our enterprise resource planning system; and the risk of being required to record significant impairment charges if our Dental segment’s goodwill or other intangible assets become impaired.
The order in which these factors appear should not be construed to indicate their relative importance or priority. We caution that these factors may not be exhaustive, accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results.
You should carefully consider these and other relevant factors, including those risk factors in Part I, Item 1A, (“Risk Factors”) in our most recent Form 10-K and information which may be contained in our other filings with the U.S. Securities and Exchange Commission, or SEC, when reviewing any forward-looking statement.
Investors should understand it is impossible to predict or identify all such factors or risks. As such, you should not consider the foregoing list, or the risks identified in our SEC filings, to be a complete discussion of all potential risks or uncertainties. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We do not undertake any obligation to release publicly any revisions to any forward-looking statements whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210713005426/en/
FAQ
What are the recent leadership changes at Patterson Companies (PDCO)?
What is the expected impact of the leadership changes on Patterson Companies (PDCO)?
Who will Tim Rogan report to following his promotion at Patterson Companies (PDCO)?
What is Eric Shirley's focus in his new role at Patterson Companies (PDCO)?
